Anti-Dyslipidemic and Anti-Diabetic Properties of Corosolic Acid: A Narrative Review

Anti-Dyslipidemic and Anti-Diabetic Properties of Corosolic Acid: A Narrative Review

Corosolic acid (CA), a natural compound derived from the Banaba tree (<i>Lagerstroemia speciosa</i>), has attracted attention for its potential therapeutic properties in the management of metabolic diseases. This narrative review aims to summarize the current evidence on the anti-dyslipi...

Full description

Bibliographic Details
Main Authors:	Rossella Cannarella, Vincenzo Garofalo, Aldo E. Calogero
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Series:	Endocrines
Subjects:	corosolic acid dyslipidemia diabetes
Online Access:	https://www.mdpi.com/2673-396X/4/3/44

Similar Items

An improved partial synthesis of corosolic acid and its conversion to highly cytotoxic mitocans
by: Niels V. Heise, et al.
Published: (2022-12-01)

Development of a high-performance liquid chromatography for analysis of corosolic acid in Lagerstroemia species and their hypoglycemic potentials
by: Gorawit Yusakul, et al.
Published: (2020-04-01)

Nrf2 activator corosolic acid meliorates alloxan induced diabetic nephropathy in mice
by: Priti S. Tidke, et al.
Published: (2017-09-01)

An in vitro investigation of the apoptosis-inducing activity of corosolic acid in breast cancer cells
by: Saade Abdalkareem Jasim, et al.
Published: (2023-04-01)

The Cardioprotective Effect of Corosolic Acid in the Diabetic Rats: A Possible Mechanism of the PPAR-γ Pathway
by: Faisal K. Alkholifi, et al.
Published: (2023-01-01)

Characterization of Corosolic Acid as a KPC-2 Inhibitor That Increases the Susceptibility of KPC-2-Positive Bacteria to Carbapenems
by: Yonglin Zhou, et al.
Published: (2020-07-01)

Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity
by: Joanna Pastwińska, et al.
Published: (2022-02-01)

Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis
by: Li-Wei Sun, et al.
Published: (2021-10-01)

Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
by: Jinwei Zhao, et al.
Published: (2022-12-01)

Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression
by: Fei-Feng Tang, et al.
Published: (2023-05-01)

Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling
by: Akiko Kawade, et al.
Published: (2023-02-01)

Corosolic Acid Inhibits Secretory Phospholipase A2IIa as an Anti-Inflammatory Function and Exhibits Anti-Tumor Activity in Ehrlich Ascites Carcinoma Bearing Mice
by: Pundalik S, et al.
Published: (2022-12-01)

Modulating the ERK1/2–MMP1 Axis through Corosolic Acid Inhibits Metastasis of Human Oral Squamous Cell Carcinoma Cells
by: Jen-Liang Chen, et al.
Published: (2021-08-01)

Corosolic Acid Protects Rat Chondrocytes Against IL-1β-Induced ECM Degradation by Activating Autophagy via PI3K/AKT/mTOR Pathway and Ameliorates Rat Osteoarthritis
by: Han H, et al.
Published: (2022-08-01)

Corosolic acid induces potent anti-cancer effects in CaSki cervical cancer cells through the induction of apoptosis, cell cycle arrest and PI3K/Akt signalling pathway
by: Yong Qian Xu, et al.
Published: (2016-04-01)

Metabolomics approach to identify the active substances influencing the antidiabetic activity of Lagerstroemia species
by: Mun-Ock Kim, et al.
Published: (2020-01-01)

Phytochemical investigations of Campsis radicans L.
by: Mirazul Islam, et al.
Published: (2020-08-01)

A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy
by: Jyotsna Needamangalam Balaji, et al.
Published: (2022-07-01)

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
by: Tenenbaum Alexander, et al.
Published: (2012-10-01)

Anti-Hyperglycemic and Anti-Dyslipidemic Activities of Glycyrrhiza Glabra Root Extract In Diabetic Rats
by: Jabbar Ahmed Qureshi , Zahida Memon , Kauser Ismail , Fizza Saher , Vanita Motiani , Zain Mushtaq
Published: (2021-12-01)

Corchorus olitorius extract exhibit anti-hyperglycemic and anti-inflammatory properties in rodent models of obesity and diabetes mellitus
by: Kabelo Mokgalaboni, et al.
Published: (2023-04-01)

Effect of <i>Eriobotrya japonica</i> Leaf Supplements on Allergic Rhinitis Symptoms and Skin Conditions in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study
by: Masumi Nagae, et al.
Published: (2023-10-01)

Comparison between 20 mg versus 40 mg dose of atorvastatin among dyslipidemic patients associated with diabetes or coronary artery disease: a randomized clinical trial
by: Hassan Aboobaid, et al.
Published: (2017-06-01)

Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation
by: Marta Tomczyk, et al.
Published: (2021-11-01)

Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3
by: Bo Ma, et al.
Published: (2018-09-01)

The use of probiotics for improving lipid profiles in dyslipidemic individuals: an overview protocol
by: Patricia M. Fortes, et al.
Published: (2018-10-01)

Hypolipidemic effect of methoxyflavone-enriched extract of Kaempferia parviflora in cholesterol-induced dyslipidemic rats
by: Somsuda Somintara, et al.
Published: (2019-04-01)

The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
by: Roxana Nartea, et al.
Published: (2023-04-01)

Impact of omega-3 fatty acids and/or plant sterol supplementation on non-HDL cholesterol levels of dyslipidemic Indian adults
by: Shweta Khandelwal, et al.
Published: (2013-01-01)

Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy
by: Qi Wang, et al.
Published: (2016-09-01)

Rutaecarpine exhibits anti-diabetic potential in high fat diet–multiple low dose streptozotocin induced type 2 diabetic mice and in vitro by modulating hepatic glucose homeostasis
by: Laishram Surbala, et al.
Published: (2020-08-01)

Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study
by: A. Mendes-Lana, et al.
Published: (2007-01-01)

Omega-3 Polyunsaturated Fatty Acids and Their Anti-Oxidant, Anti-Inflammatory and Neuroprotective Effects in Diabetic Retinopathy: A Narrative Review
by: Sarah Fathima, et al.
Published: (2023-07-01)

Risk factors and quality of life of dyslipidemic patients in Lebanon: A cross-sectional study
by: Akram Farhat, et al.
Published: (2019-04-01)

The Assessment of the Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Dyslipidemic Obese Children
by: Tuğçe Damla Dilek, et al.
Published: (2019-09-01)

Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia
by: Milena Magalhães Aleluia, et al.
Published: (2017-04-01)

Diabetes Mellitus and Associated Factors Among Adult HIV Patients on Highly Active Anti-Retroviral Treatment
by: Duguma F, et al.
Published: (2020-10-01)

Mass-Spectrometry-Based Lipidomics Discriminates Specific Changes in Lipid Classes in Healthy and Dyslipidemic Adults
by: Salvador Sánchez-Vinces, et al.
Published: (2023-02-01)

Anti-Obesity and Anti-Dyslipidemic Effects of <i>Salicornia arabica</i> Decocted Extract in Tunisian <i>Psammomys obesus</i> Fed a High-Calorie Diet
by: Souhaieb Chrigui, et al.
Published: (2023-03-01)

Dyslipidemia among patients with type 2 diabetes mellitus visiting Specialized Center for Diabetes and Endocrinology
by: Badri Fadhil:, et al.
Published: (2014-01-01)